Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Databases for assessing the outcomes of the treatment of patients with congenital and paediatric cardiac disease--the perspective of critical care.

Authors:
Joan M LaRovere Howard E Jeffries Ramesh C Sachdeva Thomas B Rice Randall C Wetzel David S Cooper Geoffrey L Bird Nancy S Ghanayem Paul A Checchia Anthony C Chang David L Wessel

Cardiol Young 2008 Dec;18 Suppl 2:130-6

Department of Paediatric Intensive Care, The Royal Brompton Hospital, London, United Kingdom.

The development of databases to track the outcomes of children with cardiovascular disease has been ongoing for much of the last two decades, paralleled by the rise of databases in the intensive care unit. While the breadth of data available in national, regional and local databases has grown exponentially, the ability to identify meaningful measurements of outcomes for patients with cardiovascular disease is still in its early stages. In the United States of America, the Virtual Pediatric Intensive Care Unit Performance System (VPS) is a clinically based database system for the paediatric intensive care unit that provides standardized high quality, comparative data to its participants [https://portal.myvps.org/]. All participants collect information on multiple parameters: (1) patients and their stay in the hospital, (2) diagnoses, (3) interventions, (4) discharge, (5) various measures of outcome, (6) organ donation, and (7) paediatric severity of illness scores. Because of the standards of quality within the database, through customizable interfaces, the database can also be used for several applications: (1) administrative purposes, such as assessing the utilization of resources and strategic planning, (2) multi-institutional research studies, and (3) additional internal projects of quality improvement or research.In the United Kingdom, The Paediatric Intensive Care Audit Network is a database established in 2002 to record details of the treatment of all critically ill children in paediatric intensive care units of the National Health Service in England, Wales and Scotland. The Paediatric Intensive Care Audit Network was designed to develop and maintain a secure and confidential high quality clinical database of pediatric intensive care activity in order to meet the following objectives: (1) identify best clinical practice, (2) monitor supply and demand, (3) monitor and review outcomes of treatment episodes, (4) facilitate strategic healthcare planning, (5) quantify resource requirements, and (6) study the epidemiology of critical illness in children.Two distinct physiologic risk adjustment methodologies are the Pediatric Risk of Mortality Scoring System (PRISM), and the Paediatric Index of Mortality Scoring System 2 (PIM 2). Both Pediatric Risk of Mortality (PRISM 2) and Pediatric Risk of Mortality (PRISM 3) are comprised of clinical variables that include physiological and laboratory measurements that are weighted on a logistic scale. The raw Pediatric Risk of Mortality (PRISM) score provides quantitative measures of severity of illness. The Pediatric Risk of Mortality (PRISM) score when used in a logistic regression model provides a probability of the predicted risk of mortality. This predicted risk of mortality can then be used along with the rates of observed mortality to provide a quantitative measurement of the Standardized Mortality Ratio (SMR). Similar to the Pediatric Risk of Mortality (PRISM) scoring system, the Paediatric Index of Mortality (PIM) score is comprised of physiological and laboratory values and provides a quantitative measurement to estimate the probability of death using a logistic regression model.The primary use of national and international databases of patients with congenital cardiac disease should be to improve the quality of care for these patients. The utilization of common nomenclature and datasets by the various regional subspecialty databases will facilitate the eventual linking of these databases and the creation of a comprehensive database that spans conventional geographic and subspecialty boundaries.

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2F978-1-4471-65
Web Search
http://link.springer.com/content/pdf/10.1007%2F978-1-4471-65
Web Search
http://search.proquest.com/openview/12094800db21d29b8261c3ff
Web Search
http://www.journals.cambridge.org/abstract_S1047951108002886
Publisher Site
http://dx.doi.org/10.1017/S1047951108002886DOI Listing
December 2008

Publication Analysis

Top Keywords

risk mortality
32
intensive care
28
pediatric risk
24
mortality prism
20
paediatric intensive
16
scoring system
12
mortality
12
care unit
12
risk
9
care
9
pediatric intensive
8
severity illness
8
pediatric
8
predicted risk
8
quantitative measurement
8
high quality
8
physiological laboratory
8
logistic regression
8
paediatric
8
patients congenital
8

Similar Publications

Hyperbaric oxygen for intracranial abscess.

Authors:
Edward O Tomoye Richard E Moon

Undersea Hyperb Med 2021 First Quarter;48(1):97-102

Departments of Anesthesiology and Medicine, Center for Hyperbaric Medicine and Environmental Physiology, Duke University, North Carolina U.S.

The term "intracranial abscess" (ICA) includes cerebral abscess, subdural empyema, and epidural empyema, which share many diagnostic and therapeutic similarities and, frequently, very similar etiologies. Infection may occur and spread from a contiguous infection such as sinusitis, otitis, mastoiditis, or dental infection; hematogenous seeding; or cranial trauma. In view of the high morbidity and mortality of ICA and the fact that hyperbaric oxygen therapy (HBO2) is relatively non-invasive and carries a low complication rate, the risk-benefit ratio favors adjunct use of HBO2 therapy in selected patients with intracranial abscess. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction.

Authors:
Uta Ceglarek Paul Schellong Maciej Rosolowski Markus Scholz Anja Willenberg Jürgen Kratzsch Uwe Zeymer Georg Fuernau Suzanne de Waha-Thiele Petra Büttner Alexander Jobs Anne Freund Steffen Desch Hans-Josef Feistritzer Berend Isermann Joachim Thiery Janine Pöss Holger Thiele

Eur Heart J 2021 Feb 27. Epub 2021 Feb 27.

Heart Center Leipzig at University of Leipzig, Department of Internal Medicine/Cardiology, Strümpellstr.. 39, 04289 Leipzig, and Leipzig Heart Institute, Leipzig, Germany.

Background : Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) still reaches excessively high mortality rates. This analysis is aimed to develop a new easily applicable biomarker-based risk score.

Methods And Results : A biomarker-based risk score for 30-day mortality was developed from 458 patients with CS complicating AMI included in the randomized CULPRIT-SHOCK trial. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Anticoagulation Management In Hemodialysis Patients With Atrial Fibrillation: Evidence And Opinion.

Authors:
An S De Vriese Gunnar Heine

Nephrol Dial Transplant 2021 Feb 27. Epub 2021 Feb 27.

AGAPLESION MARKUS KRANKENHAUS, Frankfurt, and Saarland University Faculty of Medicine, Homburg, Germany.

In the absence of robust evidence to guide clinical decision making, the optimal approach to prevent stroke and systemic embolism in hemodialysis patients with atrial fibrillation (AF) remains moot. In this position paper, studies on oral anticoagulation in hemodialysis patients with AF are highlighted, followed by an evidence-based conclusion, a critical analysis to identify sources of bias, and practical opinion-based suggestions on how to manage anticoagulation in this specific population. It remains unclear whether AF is a true risk factor for embolic stroke in hemodialysis. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Disentangling the obesity paradox in upper gastrointestinal cancers: Weight loss matters more than body mass index.

Authors:
Shria Kumar Nadim Mahmud David S Goldberg Jashodeep Datta David E Kaplan

Cancer Epidemiol 2021 Feb 26;72:101912. Epub 2021 Feb 26.

Division of Gastroenterology and Hepatology, Perelman School of Medicine at the University of Pennsylvania, United States; Gastroenterology Section, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, United States. Electronic address:

Objectives: The obesity paradox, whereby obesity appears to confer protection against cancer-related mortality, remains controversial. This has not yet been evaluated in upper gastrointestinal cancers.

Designs: We identified esophageal, cardia, and non-cardia gastric adenocarcinomas in the Veterans Health Administration between 2006-2016. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Gut microbial metabolite TMAO portends prognosis in acute ischemic stroke.

Authors:
Jianli Zhang Liankun Wang Jinle Cai Aidi Lei Caiwen Liu Ruidian Lin Li Jia Yingzi Fu

J Neuroimmunol 2021 Feb 20;354:577526. Epub 2021 Feb 20.

Department of Neurology, Heilongjiang Province Hospital, Harbin, China. Electronic address:

Background: Over the recent years, the role of trimethylamine N-oxide (TMAO) as a gut-derived metabolite mediating cardiovascular disease pathogenesis has been under particularly intense scrutiny. The aim was to explore whether TMAO levels were associated with clinical severity or functional outcome in Chinese patients with ischemic stroke.

Methods: This is a single-center, prospective cohort study from Xiamen, China. Read More

View Article and Full-Text PDF
February 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap